Page 32 - 《中国药房》2022年6期
P. 32

基于内分泌科医师问卷调查结果评价武汉市胰岛素类药品集中

        采购分组办法的合理性及可行性                                     Δ


        胡惠子    1,2,3* ,文小桐 ,杨 莹 ,毛李宁 ,王兆仑 ,罗 佳 ,张维纯                     1,2,3 # ,毛宗福 ,崔 丹 (1.湖北中医药
                                                               2,3
                                                      2,3
                                             2,3
                                    2,3
                          2,3
                                                                                             2,3
                                                                                    2,3
        大学管理学院,武汉 430065;2.武汉大学全球健康研究中心,武汉 430071;3.武汉大学健康学院,武汉
        430071)
                            +
        中图分类号 R95;R977.1 5         文献标志码 A           文章编号     1001-0408(2022)06-0666-07
        DOI   10.6039/j.issn.1001-0408.2022.06.04
        摘   要   目的 调查内分泌科医师对胰岛素类药品临床转换替代的态度,为完善胰岛素集中带量采购方案提供依据。方法 采用问
        卷调查法,以南昌市三级甲等综合医院的内分泌科医师为调查对象,从代际层面、议价组层面、通用名层面和厂牌/规格层面4个维
        度调查内分泌医师认可的胰岛素可转换替代比例。结果 共成功发放问卷89份,占南昌市三级甲等综合医院在岗内分泌科医师
        (共111名)的80.2%;回收89份问卷,其中1份为无效问卷,有效率为98.9%。调查结果显示,在代际层面,93.2%的内分泌科医师
        会首选胰岛素类似物。在议价组层面,医师认可的组三与组四药品间相互转换替代比例的加权平均数为63.9%。在通用名、厂
        牌/规格层面,医师认可的各组药品间相互转换替代比例的加权平均数均在70%以上。结论 武汉市胰岛素分组办法较为合理,能
        实现组内胰岛素安全临床转换替代,建议取消长效人胰岛素竞价组;组内药品间可转换替代比例的加权平均数均较高,建议提高
        胰岛素约定采购量,并进行“量价挂钩”谈判;受访医师选用胰岛素起始治疗方案时更注重疗效、安全等因素,故胰岛素的替换要以
        临床疗效、用药安全为前提。
        关键词 胰岛素;临床转换替代;武汉;南昌;药品集中采购;内分泌科医师;分组办法;问卷调查

        Evaluation of the rationality and feasibility of the grouping method for centralized procurement of insulin
        drugs in Wuhan based on the results of questionnaire survey among endocrinology physicians
                                                                             2,3
                                 2,3
                                              2,3
                                                            2,3
        HU Huizi 1,2,3 ,WEN Xiaotong ,YANG Ying ,MAO Lining ,WANG Zhaolun ,LUO Jia ,ZHANG Weichun       1,2,3 ,
                                                                                      2,3
        MAO Zongfu ,CUI Dan (1. School of Management,Hubei University of Chinese Medicine,Wuhan 430065,
                               2,3
                    2,3
        China;2. Global Health Institute,Wuhan University,Wuhan 430071,China;3. School of Health Sciences,
        Wuhan University,Wuhan 430071,China)
        ABSTRACT    OBJECTIVE To investigate the attitude of endocrinology physicians to clinical conversion and substitution of
        insulin drugs,and to provide basis for improving the centralized procurement program of insulin. METHODS The proportion of
        convertible and substitutable insulin recognized by endocrinology physicians was investigated by questionnaire from 4 dimensions:
        intergenerational level,bargaining group level,common name level and brand/specification level. The subjects were endocrinology
        physicians in the third grade class A general hospitals in Nanchang. RESULTS A total of 89 questionnaires were successfully
        distributed,accounting for 80.2% of the on-the-job endocrinology physicians (111 in total) in the third grade class A general
        hospitals in Nanchang. Eighty-nine questionnaires were collected,one of which was invalid,and the effective rate was 98.9%. At
        the intergenerational level,93.2% of endocrinology physicians preferred insulin analogues. At the bargaining group level,the
        weighted average of the convertible ratio between group 3 and group 4 approved by physicians was 63.9% . At the levels of
        common name and brand/specification,the weighted averages of convertible proportion of each group were more than 70% .
        CONCLUSIONS The method of insulin grouping in Wuhan is reasonable which can complete clinical conversion and substitution
        of insulin in the group safely. It is suggested to cancel long-acting human insulin group. The weighted average of the proportion of
        convertible and substitutable drugs in the group is high. It is suggested to increase the agreed purchase volume of insulin and
        conduct“volume price linked”negotiations. When the surveyed physicians choose the initial treatment scheme of insulin,they pay
        more attention to the factors such as efficacy and safety,so the replacement of insulin should be based on the clinical efficacy and
                                                            drug safety.
            Δ 基金项目:胰岛素用药公共安全与胰岛素采购政策研究项目
                                                            KEYWORDS     insulin;clinical conversion and substitution;
        (No.250000194)
            *硕士研究生。研究方向:医药经济与管理。E-mail:972433470@           Wuhan; Nanchang; centralized  procurement  of  drugs;
        qq.com                                              endocrinology physicians; grouping methods; questionnaire
            # 通信作者:副教授,硕士生导师。研究方向:医药经济与管理。                  survey
        E-mail:1712644688@qq.com


        ·666 ·  China Pharmacy 2022 Vol. 33 No. 6                                    中国药房    2022年第33卷第6期
   27   28   29   30   31   32   33   34   35   36   37